全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Arterial Hypertension and Skin Allergy Are Risk Factors for Progression from Dengue to Dengue Hemorrhagic Fever: A Case Control Study

DOI: 10.1371/journal.pntd.0003812

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Currently, knowledge does not allow early prediction of which cases of dengue fever (DF) will progress to dengue hemorrhagic fever (DHF), to allow early intervention to prevent progression or to limit severity. The objective of this study is to investigate the hypothesis that some specific comorbidities increase the likelihood of a DF case progressing to DHF. Methods A concurrent case-control study, conducted during dengue epidemics, from 2009 to 2012. Cases were patients with dengue fever that progressed to DHF, and controls were patients of dengue fever who did not progress to DHF. Logistic regression was used to estimate the association between DHF and comorbidities. Results There were 490 cases of DHF and 1,316 controls. Among adults, progression to DHF was associated with self-reported hypertension (OR = 1.6; 95% CI 1.1-2.1) and skin allergy (OR = 1.8; 95% CI 1.1-3.2) with DHF after adjusting for ethnicity and socio-economic variables. There was no statistically significant association between any chronic disease and progression to DHF in those younger than 15 years. Conclusions Physicians attending patients with dengue fever should keep those with hypertension or skin allergies in health units to monitor progression for early intervention. This would reduce mortality by dengue.

References

[1]  WHO. Dengue and severe dengue. Fact sheet N°117. 2014.
[2]  Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013; 496: 504–507. doi: 10.1038/nature12060. pmid:23563266
[3]  WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control; 2009. pmid:23762963
[4]  Halstead SB. Dengue haemorrhagic fever. A public health problem and a field for research. Bull World Helth Organ. 1980; 58: 1–21.
[5]  Halstead SB. Dengue. Lancet. 2007; 370(9599):1644–52. pmid:17993365 doi: 10.1016/s0140-6736(07)61687-0
[6]  Halstead SB, Mahalingam S, Morovich MA, Ubol S, Mosser DM. Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis. 2010; 10: 712–722. doi: 10.1016/S1473-3099(10)70166-3. pmid:20883967
[7]  Murray NE, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clinical Epidemiology. 2013; 5; 299–309. doi: 10.2147/CLEP.S34440. pmid:23990732
[8]  Bravo JR, Guzmán MG,Kourí GP. Why dengue haemorhagic fever in Cuba? 1. Individual risk factors for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 1987; 81: 816–820. pmid:3450004 doi: 10.1016/0035-9203(87)90041-1
[9]  Cunha RV, Schatzmayr HG, Miagostovich MP, Barbosa AMA, Paiva FG, Miranda RMO, et al. Dengue epidemic in the State of Rio Grande do Norte, Brazil, 1997. Trans R Soc Trop Med Hyg 1999; 93: 247–49. pmid:10492750 doi: 10.1016/s0035-9203(99)90008-1
[10]  Figueiredo MA, Rodrigues LC, Barreto ML, Lima JWO, Costa MCN, Morato V, et al. Allergies and Diabetes as Risk Factors for Dengue Hemorrhagic fever: Results of a Case Control Study. PLoS Negl. Trop. Dis. 2010; 4: 699–705. doi: 10.1371/journal.pntd.0000699
[11]  Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, et al. Diabetes with Hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012; 6(5):e1641. doi: 10.1371/journal.pntd.0001641. pmid:22563519
[12]  Teixeira MG, Costa MC, Barreto F, Barreto ML. Dengue: twenty Five years since reemergence in Brazil. Cad. Saúde Pública. 2009; 25. doi: 10.1590/S0102.
[13]  WHO. Dengue hemorrhagic fever: Diagnosis, Treatment, Prevention and Control. Geneva; 1997.
[14]  Savoia C, Sada L, Zezza L, Pucci L, Lauri FM, Befani A, et al. Vascular Inflammation and Endothelial Dysfunction in Experimental Hypertension. International Journal of Hypertension. 2011. doi: 10.4061/2011/281240.
[15]  Hage FG. C-reactive protein and Hypertension. J Hum Hypertens. 2014; 28(7):410–5. doi: 10.1038/jhh.2013.111. pmid:24226100
[16]  Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant. 2006; 21: 850–853. doi: 10.1093/ndt/gfl01. pmid:16464884
[17]  Guzman MG, Alvarez M, Halstead SB. Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013; 158(7):1445–59. doi: 10.1007/s00705-013-1645-3. pmid:23471635

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133